Equities

Optimus Healthcare Services Inc

OHCS:PKC

Optimus Healthcare Services Inc

Actions
  • Price (USD)0.069
  • Today's Change0.00 / 0.00%
  • Shares traded10.00
  • 1 Year change-94.00%
  • Beta1.2717
Data delayed at least 15 minutes, as of Jul 05 2024 14:30 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Optimus Healthcare Services, Inc. is a dedicated to advancing access to clinical trial research through its portfolio company Clinical Research Alliance, Inc. (CRA). CRA provides services to a team of dedicated oncologists across the Tri-State area that are united by a shared commitment to conduct clinical research. CRA provides independent, community-based oncology practices and hospitals in diverse communities with the necessary infrastructure and support to enroll their patients in clinical trials without the patients having to leave their physicians' offices, hospitals or their local communities. CRA's focus is on oncology practices, as well as hospitals in diverse communities. CRA contracts with pharmaceutical companies and Contract Research Organizations (CRO) to conduct clinical trials (Phases I-IV) for investigational new drugs, biologics and medical devices. CRA's customers consist primarily of large and mid-sized pharmaceutical and biotech companies.

  • Revenue in USD (TTM)1.57m
  • Net income in USD-8.57m
  • Incorporated1990
  • Employees12.00
  • Location
    Optimus Healthcare Services Inc1400 Old Westbury RoadSuite 306, Suite 305WESTBURY 11590United StatesUSA
  • Phone+1 (516) 806-4201
  • Websitehttps://www.optimushealthcare.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Helius Medical Technologies Inc-100.00bn-100.00bn2.34m26.00--0.4139----------2.24-----------98.37---143.57--37.27---1,580.663.26-------18.176.1437.11------
Bioelectronics Corp1.61m-289.82k2.47m9.00------1.53-0.00002-0.000020.00007-0.00066.329.2014.53---113.86-383.59----49.4351.48-18.01-143.480.0099-0.4909----94.01-5.0975.01------
Catheter Precision Inc439.00k-6.85m2.68m14.00--0.1447--6.11-1.03-1.030.06592.450.01150.37595.7431,357.14-17.89---19.64--94.31---1,559.68--0.8047--0.004--3,057.14---165.67------
SINTX Technologies Inc2.78m-8.88m2.76m43.00--0.0117--0.9949-389.94-389.9474.21383.240.1381.625.8464,534.88-44.03-45.71-57.11-57.3667.9658.47-318.99-681.801.67--0.0229--68.2994.2449.75--54.10--
Tenon Medical Inc3.21m-14.33m2.78m21.00--8.57--0.8644-7.24-7.241.430.97240.41082.787.25153,047.60-183.10---269.43--54.70---445.77--2.35--0.00--323.73--17.63------
Heart Test Laboratories Inc18.60k-6.39m2.89m12.00--32.49--155.44-0.4912-0.49120.00090.13570.00260.0092.531,550.00-89.51---120.71--67.31---34,362.42--4.70-16.410.0547---64.16---31.61------
Vycor Medical Inc1.44m-425.52k2.93m8.00------2.04-0.0133-0.01350.0425-0.10781.590.66726.81179,572.50-11.22-47.86----89.4889.60-7.04-35.420.0861-0.0247----19.43-0.654246.49---31.77--
Avinger Inc7.62m-16.13m2.97m68.00------0.3897-18.16-18.167.49-2.560.40841.206.38112,102.90-102.83-70.93---131.5722.4330.87-251.78-208.910.4764-10.021.38---7.51-0.673632.76---24.21--
Invo Bioscience Inc4.25m-7.08m2.97m25.00------0.6992-5.68-5.682.590.00390.34739.5030.72169,953.20-57.87-94.63-128.00-151.4539.9074.91-166.64-343.110.1629-5.860.9965--267.3843.6226.24--87.09--
BIOLASE Inc48.83m-38.26m3.01m157.00------0.0616-20.50-20.508.640.00811.282.219.00311,006.40-55.75-49.28-118.58-85.8034.2535.27-43.56-50.720.6409-5.980.9812--1.451.27-30.39--18.63--
Optimus Healthcare Services Inc1.57m-8.57m3.16m12.00------2.01-0.2139-0.21390.039-0.18840.9263--3.12130,884.20-505.59------83.03---545.81-----7.49----22.88---3.51------
AccuStem Sciences Inc0.00-1.74m3.87m3.00---------0.1537-0.15370.00-0.23090.00----0.00-1,168.46--------------------------45.26------
Applied DNA Sciences Inc5.52m-12.50m3.97m53.00------0.7191-17.13-17.137.67-0.05580.389310.384.64104,110.80-87.15-88.57-111.09-121.9133.9844.35-223.89-113.261.54-------26.4327.92-18.73--33.80--
Predictive Oncology Inc1.96m-14.78m3.97m34.00--0.9702--2.03-3.66-3.660.48530.99770.10991.714.9557,642.65-82.89-91.80-108.54-126.2964.1864.64-754.19-1,419.991.35--0.0093--18.244.7545.67--5.44--
Venus Concept Inc73.30m-37.39m4.01m304.00------0.0548-6.69-6.6913.12-3.540.74091.062.21241,125.00-37.61-32.71-56.83-44.0168.3768.16-50.77-48.501.35-3.441.40---23.2628.3114.76---35.08--
Data as of Jul 05 2024. Currency figures normalised to Optimus Healthcare Services Inc's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.